- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06330129
Validity and Reliability of Trunk Strength Device (PEGASUS)
March 18, 2024 updated by: Jacopo Vitale, Schulthess Klinik
Validity and Reliability of Trunk Muscle Strength Assessements With Isometric Dynamometry
The study aims to evaluate the accuracy and consistency of assessing trunk muscle strength using an isometric device (Pegasus, Leipzig, Germany).
Thirty healthy volunteers will undergo maximal isometric strength testing with the device, repeated one week later to assess repeatability.
Surface electrodes will measure muscle activation, while MRI scans will assess structural condition.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
The aim of the study is to assess the validity and repeatability of trunk muscle strength evaluation using an isometric device (Pegasus, Leipzig, Germany) and to investigate it.
Thirty healthy volunteer participants will undergo testing of maximal isometric (non-moving) strength using this device.
The same strength measurement procedure will be repeated one week later for all participants to determine if the measurements are repeatable, i.e., if the device is capable of providing similar strength data in two closely timed measurements.
To assess whether the device actually provides reliable strength data for the trunk muscles, surface electrodes will be additionally placed on the involved muscles to understand the extent of neural activation of these muscles during the test.
Additionally, an MRI examination will be conducted for all study participants to assess the structural condition of the trunk muscles.
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jana Frangi, MSc
- Phone Number: +41443857048
- Email: jana.frangi@kws.ch
Study Contact Backup
- Name: Jacopo Vitale, Dr.
- Phone Number: +41443857148
- Email: jacopo.vitale@kws.ch
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- both male and female subjects
- age between 18 and 59 years
- BMI < 30 kg/m2
- cognitively intact (self-reported)
- autonomous walking
Exclusion Criteria:
- age under 18 years or over 60 years
- any prior spinal surgery or other musculoskeletal surgery having an impact on movement
- acute or chronic back pain in the last 6 months(self-reported)
- pregnancy (self-reported)
- inability to perform the planned set of activities included in the study (e.g. maximal voluntary contraction torque test)
- inability to give consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Healthy subjects
30 healthy subjects undergo trunk muscle strength assessement using the Pegasus device, with repeated measurements to evaluate repeatability and correlation with both surface electromyography (EMG) and MRI scans of trunk muscles.
|
The intervention aims to assess the construct validity of trunk flexor, extensor, and rotator muscle strength using the CTT PEGASUS isometric dynamometer (Leipzig, Germany).
This involves correlating muscle strength measured isometrically with its physiological determinants: MRI-based anatomical cross-sectional area (CSA) in the lumbar region and muscle activation measured via surface electromyography (EMG) of spine and trunk muscles.
Additionally, the intervention will assess the test-retest reliability of isometric strength of trunk flexors, extensors, and rotators.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
maximal isometric trunk muscle strength
Time Frame: 1 hour
|
The computer-assisted test and trainig device (CTT) PEGASUS provides data on back muscle strength in isometric conditions, which constitutes the main endpoint of the present project.
|
1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MRI muscle morphology
Time Frame: 0.5-1hour
|
the anatomical crosssectional area (CSA) of trunk muscles (multifidus, erector spinae, rectus abdominis, and obliquus externus abdominis) evaluated through an abdominal MRI.
|
0.5-1hour
|
Electromyography (EMG) activity
Time Frame: 1hour
|
the root mean square EMG activity recorded during maximal and submaximal voluntary contractions of respective muscles.
|
1hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 15, 2024
Primary Completion (Estimated)
March 31, 2025
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
March 4, 2024
First Submitted That Met QC Criteria
March 18, 2024
First Posted (Actual)
March 26, 2024
Study Record Updates
Last Update Posted (Actual)
March 26, 2024
Last Update Submitted That Met QC Criteria
March 18, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- Pegasus01_Val
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Trunk Muscle Strength
-
University of Erlangen-Nürnberg Medical SchoolCompletedMuscle Strength | Trunk Stability | Golf Specific PerformanceGermany
-
Dilara Özen OrukMuğla Sıtkı Koçman UniversityRecruitingStrength | Trunk | Endurance | Plantar PressureTurkey
-
Okan UniversityCompletedExercise Addiction | Upper Extremity | Wrestling | Trunk Muscle StrengthTurkey
-
Universidade Estadual do Norte do ParanáCompletedMuscle Strength | Muscle Strength DynamometerBrazil
-
University GhentCompletedReliability and Validity of Strength Measurement of the Lower Limbs in Typically Developing ChildrenChildren | Muscle Strength | Knee | Reproducibility of Results | Muscle Strength DynamometerBelgium
-
University Hospital, Strasbourg, FranceTerminated
-
Koç UniversityCompletedMuscle Strength | Posture | Abdominal MuscleTurkey
-
Riphah International UniversityRecruiting
-
Rodrigo Antonio Carvalho AndrausNot yet recruiting
-
Quiropraxia y EquilibrioSuspended
Clinical Trials on CTT Pegasus
-
Institute of Child HealthUnknownEfficacy of PEGASUSUnited Kingdom
-
Shanghai Wallaby Medical Technologies Co.,Inc.Phenox GmbHRecruiting
-
University of California, San DiegoSan Diego Veterans Healthcare SystemCompletedPosttraumatic Stress DisorderUnited States
-
University of WashingtonNational Institute of Neurological Disorders and Stroke (NINDS); Washington... and other collaboratorsCompletedTBI (Traumatic Brain Injury)Argentina, Chile, Paraguay
-
L.V. Prasad Eye InstituteCompletedPrimary Congenital Glaucoma | Developmental Glaucoma | Infantile GlaucomaIndia
-
National Taiwan University HospitalCompletedEnd Stage Renal Disease | Chronic Hepatitis CTaiwan